SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
SUTRO BIOPHARMA reports 2018 executive compensation
By ExecPay News
Published: April 25, 2019
SUTRO BIOPHARMA reported fiscal year 2018 executive compensation information on April 25, 2019.
In 2018, three executives at SUTRO BIOPHARMA received on average a compensation package of $5.5M, a 741% increase compared to previous year.
Average pay of disclosed executives at SUTRO BIOPHARMA
William J. Newell, Chief Executive Officer, received $8.7M in total, which increased by 1,136% compared to 2017. 78% of Newell's compensation, or $6.8M, was in option awards. Newell also received $301K in non-equity incentive plan, $482K in salary, as well as $1.1M in stock awards.
Trevor Hallam, Chief Scientific Officer, received a compensation package of $4.4M, which increased by 548% compared to previous year. 67% of the compensation package, or $3M, was in option awards.
Arturo Molina, M.D., M.S., FACP, Chief Medical Officer, earned $3.4M in 2018, a 486% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 25, 2019.